Borsini F. Models for depression in drug screening and preclinical studies: Future directions. World J Pharmacol 2012; 1(1): 21-29 [DOI: 10.5497/wjp.v1.i1.21]
Corresponding Author of This Article
Franco Borsini, Central and Peripheral Nervous System and General Pharmacology Area - R&D, Sigma-tau SpA, Socio Unico, Via Pontina Km 30400, 00040 Pomezia, Italy. franco.borsini@sigma-tau.it
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/